Sort
30,917 grants matching “tumor microenvironment”
Multi-receptor Targeting of Glioblastoma
$642,795Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2021 · CA
Targeting complement to enhance antitumor immunity and control malignant effusions in patients with recurrent epithelial ovarian cancer
$642,760Emese Zsiros · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Targeting anoctamin 6 to disrupt trogocytosis of cancer-associated fibroblasts
$642,755Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · CA
Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping
$642,732Brooke E Howitt · Stanford University · R37 · FY2025 · CA
Neuroimmunotoxicology: autoimmunity, inflammation, age, environmental agents
$642,713Gaylia Jean Harry · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
(PQD5) Avatar-directed Treatment for Ovarian Cancer
$642,667Saravut Weroha · Mayo Clinic Rochester · R01 · FY2015 · CA
The Epidemiology of Immune Responses in Colorectal Cancer
$642,645Stephen B Gruber · University Of Southern California · R01 · FY2015 · CA
Deciphering the Acidic Tumor Environment: A Phase I/IIa Study of Pre-Operative Multiparametric MRI and pHLIP® ICG Intra-Operative Fluorescence Imaging of Primary Breast Cancer
$642,556Monica Morrow · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Immune receptor degradation for immune evasion of head and neck cancer
$642,488Dohun Pyeon · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · DE
Engineering T Cell Adoptive Therapy for Glioblastoma
$642,482Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2025 · NS
Targeted radiation and immunocytokine therapy for CEA positive malignancies
$642,450John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
A premalignant chronology of cell-state variability in basal-like breast cancer
$642,376Kevin A Janes · University Of Virginia · R01 · FY2023 · CA
PPARD hyperactivation promotes pancreatic intraepithelial neoplasia progression into pancreatic ductal adenocarcinoma
$642,368Imad Shureiqi · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$642,352Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Re-engineering differential regulation of ferroptosis in melanoma microenvironment
$642,352Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Naive T cells in Cancer Immune Evasion and Immunotherapy
$642,318Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Remodeling Chromatin and the Tumor Microenvironment: Direct Oncogenesis and Therapeutic Targeting
$642,266David E Fisher · Massachusetts General Hospital · P01 · FY2025 · CA
MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer
$642,150Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Engineering synthetic feedback control in T cell signaling for anti-tumor immunity
$642,044Hao Yuan Kueh · University Of Washington · R01 · FY2024 · CA
CAR neutrophils produced in vivo to remodel tumor microenvironment and treat glioblastoma
$641,936Xiaoping Bao · Purdue University · R01 · FY2025 · CA
Simultaneous Microwave and MR Imaging for Improved Diagnosis of Breast Abnormalities
$641,864Keith D. Paulsen · Dartmouth College · R01 · FY2020 · CA
Impact of hypoxia on lipid metabolism in obesity-driven breast cancer progression
$641,634Dorothy Teegarden · Purdue University · R01 · FY2025 · CA
Targeting Kinesin Family Member 15 for the Treatment of Cancer
$641,589Andrew K Godwin · University Of Kansas Medical Center · R01 · FY2017 · CA
Imaging Modulation of Immune Phenotype
$641,412Katherine W Ferrara · Stanford University · R01 · FY2023 · CA
Imaging Modulation of Immune Phenotype
$641,412Katherine W Ferrara · Stanford University · R01 · FY2022 · CA